News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Japanese Pharmas Launch $6.4M VC Fund For U.S. And Europe Anticancer Start-Ups



10/19/2005 5:09:10 PM

8/24/2005. Two publicly traded Japanese drugmakers have teamed up with an investment vehicle that will aim to invest in American and European anticancer start-ups. Daiichi Pharmaceutical Co. Ltd. and MediBic Alliance Co. Ltd. plan to put roughly Y700 million ($6.4 million) into what Ari Zarah, a member of the MediBic investment team described as a "very focused fund."



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES